ThermoGenesis Corp. (NASDAQ: KOOL) has their focus on the regenerative medicine market. This focus inspired the company to create a wholly-owned subsidiary named Vantus Inc. This subsidiary is a veterinary stem cell laboratory service that has collaborations with the UC Davis School of Veterinary Medicine’s Center for Equine Health and its Stem Cell Regenerative Medicine group to conduct research and development to enhance the collecting, processing, and storing of stem cells. For further information, visit the Company’s web site at www.thermogenesis.com.
- 17 years ago
QualityStocks
ThermoGenesis Corp. (NASDAQ: KOOL)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – GlobalTech Corp. (GLTK) Advancing AI and Data Solutions with Diversified Portfolio
GlobalTech (OTC: GLTK) is a diversified technology holding company focused on AI, big data, and digital…
-
QualityStocksNewsBreaks – SuperCom Ltd.’s (NASDAQ: SPCB) PureSecurity(TM) Suite Sets New Standard Through Key Contract Win
SuperCom (NASDAQ: SPCB) has secured a national electronic monitoring contract in Germany valued at up to…
-
QualityStocksNewsBreaks – BluSky AI Inc.’s (BSAI) Modular Neocloud Platform Set to Power AI Era
BluSky AI (OTC: BSAI) is emerging as a key player in the rapidly growing neocloud market—a…